Ken Anderson, MD, on Therapeutic Advances in Multiple Myeloma
Dr. Ken Anderson gives a comprehensive update on research and treatment of multiple myeloma, including new advances presented at the American Society of Hematology Annual Meeting in 2022.
Multiple Myeloma Patient Symposium Video Presentations
The Latest From Experts
The following presentations were recorded for the virtual Multiple Myeloma Patient Education Symposium, hosted by Dana-Farber Cancer Institute. A live Q&A session will be held via Zoom on February 18, 2023, at 11:00 ET (Passcode: 210383). Please submit questions by February 15 to mmptsymposium@partners.org.
The complete playlist for the 2023 Multiple Myeloma Patient Education Symposium
Update in Myeloma, presented by Kenneth Anderson, MD
The Promise of Early Detection and Interception in Myeloma, presented by Irene Ghobrial, MD
CAR T-cells in Multiple Myeloma, presented by Adam Sperling, MD, PhD
Multiple Myeloma: A Patient's Experience, presented by James and Kathleen Bond
The Ongoing Evolution of Systemic Therapy for Newly Diagnosed Multiple Myeloma, presented by Clifton Mo, MD
Future Directions for Novel and Next Generation Therapy in Multiple Myeloma, presented by Paul Richardson, MD
Updates in Managing Bone Disease in Multiple Myeloma, presented by Monique Hartley-Brown, MD, MMSc
Myeloma 101: Diagnosis, Prognosis, and Risk, presented by Nikhil Munshi, MD
Bispecific Antibodies in Multiple Myeloma, presented by Omar Nadeem, MD
Symptom Management in Multiple Myeloma, presented by Shonali Midha, MD
Updates on AL Amyloidosis Treatment: What Is New in 2023, presented by Giada Bianchi, MD
New Patient Appointments
For adults: 877-442-3324
For children: 888-733-4662
Expert Care and Treatment for Multiple Myeloma
The Multiple Myeloma Program within the Hematologic Oncology Treatment Center includes physicians, clinicians, and research scientists who work together on promising new therapies.
Your care team will collaborate to develop a comprehensive, personalized treatment plan that offers the most advanced therapies and an array of supportive resources.